1.Kidney Disease: Improving Global Outcomes(KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Kidney International Supplements. 2017;
7(1):1–59.
http://doi.org/10.1016/j.kisu.2017.04.001
2.Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease-a systematic review and meta-analysis.
PLoS One 2016;
11, e0158765.
http://doi.org/10.1371/journal.pone.0158765
5.Aucella F, Valente GL, Catizone L. The role of physical activity in the CKD Setting.
Kidney and Blood Pressure Research. 2014;
39(2-3):97–106.
http://doi.org/10.1159/000355783
6.Porter AC, Lash JP, Xie D, Pan Q, DeLuca J, Kan-thety R, et al. Predictors and outcomes of health-related quality of life in adults with CKD.
Clinical journal of American Society of Nephrology: CJASN. 2016;
11(7):1154–62.
http://doi.org/10.2215/CJN.09990915
7.Baber U, Auguste U. Patients with chronic kidney disease/diabetes mellitus: the high risk profile in acute coronary syndrome.
Current Cardiology Reports. 2013;
15(8):386.
http://doi.org/10.1007/s11886-013-0386-y
8.Greco A, Paroni G, Seripa D, Addante F, Dagostino MP, Aucella F. Frailty, disability and physical exercise in the aging process and in chronic kidney disease.
Kidney and Blood Pressure Research. 2014;
39(2-3):164–8.
http://doi.org/10.1159/000355792
9.Rampersad C, Joseph D, Harasemiw O, Brar RS, Komenda P, Rigatto C. Change in physical activity and function in patients with baseline advanced nondialysis CKD.
Clinical journal of American Society of Nephrology: CJASN. 2021;
16(12):1805–12.
http://doi.org/10.2215/CJN.07050521
11.Chung YC, Yeh ML, Liu YM. Effects of intradialytic exercise on the physical function, depression and quality of life for haemodialysis patients: a systematic review and meta‐ analysis of randomised controlled trials.
Journal of Clinical Nursing 2017;
26(13-14):1801–13.
http://doi.org/10.1111/jocn.13514
12.Pereira A, Midão L, Almada M, Costa E. Pre-Frailty and frailty in dialysis and pre-dialysis patients: A systematic review of clinical and biochemical markers.
International Journal of Environmental Research and Public Health. 2021;
18(18):9579.
http://doi.org/10.3390/ijerph18189579
13.Janmaat CJ, Diepen MV, Hagen CCE, Rotmans JI, Dekker FW, Dekkers OM. Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis.
Clinical Epidemiology. 2018;
10, 613–22.
http://doi.org/10.2147/CLEP.S153367
14.Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews for interventions version 6.3[Internet]. London, United Kingdom: Cochrane collaboration; 2011). [cited 2023 March 20]. Available from:
https://training.cochrane.org/handbook/current
15.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
BMJ. 2021;
372, n71.
https://doi.org/10.1136/bmj.n71
16.Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials.
British Medical Journal. 2019;
366, l4898.
https://doi.org/10.1136/bmj.l4898
18.Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.
British Medical Journal. 1997).
315(7109):629–34.
19.Farrington K, Covic A, Nistor I, Aucella F, Clyne N, Vos LD, et al. Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.
Nephrology Dialysis Transplantation. 2017;
32(1):9–16.
https://doi.org/10.1093/ndt/gfw411
20.Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
American Journal of Kidney Disease. 2003;
41(1):1–12.
https://doi.org/10.1053/ajkd.2003.50007
22.Yi YJ, Kim EJ. The effects of accessibility to medical facilities and public transportation on perceived health of urban and rural elderly: using generalized ordered logit model. The Korean regional development association. 2015). 27(1):65–87.
23.Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A. Frailty and chronic kidney disease: current evidence and continuing uncertaintie.
Clinical Kidney Journal. 2018;
11(2):236–45.
https://doi.org/10.1093/ckj/sfx134
24.Wu X, Yang L, Wang Y, Wang C, Hu R, Wu Y. Effects of combined aerobic and resistance exercise on renal function in adult patients with chronic kidney disease: a systematic review and meta-analysis.
Clinical rehabilitation. 2020;
34(7):851–65.
http://doi.org/10.1177/0269215520924459
25.Cui H, Wang Z, Wu J, Liu Y, Zheng J, Xiao W, et al. Chinese expert consensus on prevention and intervention for elderly with sarcopenia(2023).
Aging Medicine. 2023;
6(2):104–15.
https://doi.org/10.1002/agm2.12245
26.Pei G, Tang Y, Tan L, Tan J, Ge L, Qin W. Aerobic exercise in adults with chronic kidney disease(CKD): a meta-analysis.
International Urology and Nephrology. 2019;
51(10):1787–95.
https://doi.org/10.1007/s11255-019-02234-x
27.Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
Jama. 2009;
301(19):2024–35.
https://doi.org/10.1001/jama.2009.681
28.Villanego F, Naranjo J, Vigara LA, Cazorla JM, Montero ME, García T, et al. Impact of physical exercise in patients with chronic kidney disease: Systematic review and meta-analysis.
Revista de la Sociedad Españ ola de Nefrologí a. 2020;
40(3):237–52.
https://doi.org/10.1016/j.nefro.2020.01.002
29.Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Sarcopenia with limited mobility: an international consensus.
Journal of American Medical Directors Association. 2011;
12(6):403–9.
https://doi.org/10.1016/j.jamda.2011.04.014
30.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people.
Age Ageing. 2010;
39(4):412–23.
https://doi.org/10.1093/ageing/afq034
31.John SG, Sigrist MK, Taal MW, McIntyre CW. Natural History of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational study.
PLoS One. 2013;
8(5):e65372.
https://doi.org/10.1371/journal.pone.0065372
32.Wyngaert KV, Van Craenenbroeck AH, Biesen WV, Dhondt A, Tanghe A, Ginckel AV, et al. The effects of aerobic exercise on eGFR, blood pressure and VO2 peak in patients with chronic kidney disease stages 3– 4: a systematic review and meta-analysis.
PLoS One. 2018;
13(9):e0203662.
https://doi.org/10.1371/journal.pone.0203662
33.O'Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting.
BMJ open. 2011;
1(2):e000308.
https://doi.org/10.1136/bmjopen-2011-000308